140 related articles for article (PubMed ID: 9246604)
21. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure.
Lopes-Martins R; Catelli M; Araújo C; Estato V; Cordeiro R; Tibiriçá E
Eur J Pharmacol; 1996 Jul; 308(3):287-94. PubMed ID: 8858301
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.
Lee CM; Jung WK; Na G; Lee DS; Park SG; Seo SK; Yang JW; Yea SS; Lee YM; Park WS; Choi IW
Cutan Ocul Toxicol; 2015 Mar; 34(1):53-60. PubMed ID: 24754407
[TBL] [Abstract][Full Text] [Related]
24. PAF and haematopoiesis: III. Presence and metabolism of platelet-activating factor in human bone marrow.
Denizot Y; Trimoreau F; Dupuis F; Verger C; Praloran V
Biochim Biophys Acta; 1995 Feb; 1265(1):55-60. PubMed ID: 7857985
[TBL] [Abstract][Full Text] [Related]
25. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex.
Marcheselli VL; Rossowska MJ; Domingo MT; Braquet P; Bazan NG
J Biol Chem; 1990 Jun; 265(16):9140-5. PubMed ID: 2160958
[TBL] [Abstract][Full Text] [Related]
26. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
[TBL] [Abstract][Full Text] [Related]
27. PAF and hematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells.
Denizot Y; Rougier F; Dupuis F; Verger C; Dulery C; Laskar M; Aldigier JC; Praloran V
Exp Hematol; 1996 Sep; 24(11):1327-32. PubMed ID: 8862444
[TBL] [Abstract][Full Text] [Related]
28. Production and metabolism of platelet-activating factor by human bone marrow cells.
Dupuis F; Rougier F; Trimoreau F; Ostyn E; Dulery C; Praloran V; Denizot Y
Res Immunol; 1997 Feb; 148(2):119-26. PubMed ID: 9226766
[TBL] [Abstract][Full Text] [Related]
29. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
Ostermann G; Hofmann B; Kertscher HP; Till U
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L
Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L
Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
[TBL] [Abstract][Full Text] [Related]
32. Presence of specific platelet-activating factor binding-sites in neuroblastoma N1E-115 cells.
Lalouette F; Diserbo M; Martin C; Verdetti J; Fatome M
Neurosci Lett; 1995 Feb; 186(2-3):173-6. PubMed ID: 7777190
[TBL] [Abstract][Full Text] [Related]
33. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor.
Brewer C; Bonin F; Bullock P; Nault MC; Morin J; Imbeault S; Shen TY; Franks DJ; Bennett SA
J Neurochem; 2002 Sep; 82(6):1502-11. PubMed ID: 12354298
[TBL] [Abstract][Full Text] [Related]
34. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists.
Ostermann G; Lorenz A; Hofmann B; Kertscher HP
J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546
[TBL] [Abstract][Full Text] [Related]
35. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM
Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
[TBL] [Abstract][Full Text] [Related]
37. Release of platelet activating factor (PAF) and eicosanoids in UVC-irradiated corneal stromal cells.
Sheng Y; Birkle DL
Curr Eye Res; 1995 May; 14(5):341-7. PubMed ID: 7648859
[TBL] [Abstract][Full Text] [Related]
38. Neuronal damage by secretory phospholipase A2: modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture.
Kolko M; Rodriguez de Turco EB; Diemer NH; Bazan NG
Neurosci Lett; 2003 Feb; 338(2):164-8. PubMed ID: 12566178
[TBL] [Abstract][Full Text] [Related]
39. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
40. Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood.
Chan WP; Levy JV
Prostaglandins; 1991 Oct; 42(4):337-42. PubMed ID: 1665568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
